Dmitry Viktorovich Duplyakov
Dmitry Viktorovich Duplyakov publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Epidemiology, on topics such as Acute Myocardial Infarction Research, Cardiac Imaging and Diagnostics and Healthcare Systems and Public Health.
- World rank
- #897,041 of 7,710,434 ranked researchers
- Rank in Russia
- #2,043 of 179,717
- Works
- 262
- Citations
- 25k
- Citations per work
- 95.8
What does Dmitry Viktorovich Duplyakov research?
Dmitry Viktorovich Duplyakov's work is mostly in Medicine (71%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences18570.8%
- Medicine18570.8%
- Everything else7729.2%
- 1Cardiology and Cardiovascular Medicine40% of their works
- 2Surgery10% of their works
- 3Epidemiology7% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Internal Medicine5% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Healthcare Systems and Public Health
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Lipoproteins and Cardiovascular Health
- Cardiovascular Function and Risk Factors
Which keywords describe Dmitry Viktorovich Duplyakov's research?
The keywords of their largest research topics: Guidelines, Myocardial Infarction, Cardiovascular Disease, Risk Factors, Diagnosis, Treatment, Acute Coronary Syndromes and ST-Segment Elevation.
- Chamber Quantification
- Cholesterol-lowering
- B-Type Natriuretic Peptide
- Anticoagulant Therapy
- Antithrombotic Therapy
- Cardiovascular Diseases
- Cardiac Imaging
- ST-Segment Elevation
- Treatment
- Risk Factors
- Myocardial Infarction
- Guidelines
- Cardiovascular Disease
- Diagnosis
- Acute Coronary Syndromes
- Heart Failure
- Coronary Artery Disease
- Prevention
- Venous Thromboembolism
- Atrial Fibrillation
- Epidemiology
- Statins
- Echocardiography
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Guidelines1173 topics
- Myocardial Infarction972 topics
- Cardiovascular Disease862 topics
- Risk Factors672 topics
- Diagnosis602 topics
- Treatment602 topics
- Acute Coronary Syndromes591 topic
- ST-Segment Elevation591 topic
- Heart Failure432 topics
- Cardiac Imaging381 topic
- Coronary Artery Disease381 topic
- Cardiovascular Diseases341 topic
- Prevention341 topic
- Antithrombotic Therapy331 topic
- Venous Thromboembolism331 topic
- Anticoagulant Therapy311 topic
- Atrial Fibrillation311 topic
- B-Type Natriuretic Peptide271 topic
- Epidemiology271 topic
- Cholesterol-lowering241 topic
- Statins241 topic
- Chamber Quantification161 topic
- Echocardiography161 topic
Where does Dmitry Viktorovich Duplyakov work?
Dmitry Viktorovich Duplyakov's main affiliation in the publication record is Samara State Medical University, Russia.
How many publications and citations does Dmitry Viktorovich Duplyakov have?
OpenAlex counts 262 works and 25,110 citations for Dmitry Viktorovich Duplyakov, an h-index of 37, ranking #897,041 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Dmitry Viktorovich Duplyakov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.